---
document_datetime: 2023-09-21 18:02:56
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/zoely-epar-all-authorised-presentations_en.pdf
document_name: zoely-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8853696
conversion_datetime: 2025-12-21 19:06:28.334419
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU number       | Invented name   | Strength        | Pharmaceutical form   | Route of administration   | Packaging         | Package size                          |
|-----------------|-----------------|-----------------|-----------------------|---------------------------|-------------------|---------------------------------------|
| EU/1/11/690/001 | Zoely           | 2.5 mg / 1.5 mg | Film-coated tablet    | Oral use                  | blister (PVC/alu) | 28 tablets (24 active + 4 placebo)    |
| EU/1/11/690/002 | Zoely           | 2.5 mg / 1.5 mg | Film-coated tablet    | Oral use                  | blister (PVC/alu) | 84 tablets (72 active + 12 placebo)   |
| EU/1/11/690/003 | Zoely           | 2.5 mg / 1.5 mg | Film-coated tablet    | Oral use                  | blister (PVC/alu) | 168 tablets (144 active + 24 placebo) |
| EU/1/11/690/004 | Zoely           | 2.5 mg / 1.5 mg | Film-coated tablet    | Oral use                  | blister (PVC/alu) | 364 tablets (312 active + 52 placebo) |